Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Short Interest Update

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX - Get Free Report) was the recipient of a significant increase in short interest in the month of April. As of April 15th, there was short interest totalling 290,200 shares, an increase of 323.6% from the March 31st total of 68,500 shares. Based on an average daily trading volume, of 1,820,000 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.8% of the shares of the company are short sold.

Biodexa Pharmaceuticals Stock Performance

Shares of BDRX traded down $0.03 during mid-day trading on Wednesday, hitting $1.46. The stock had a trading volume of 15,801 shares, compared to its average volume of 585,765. The business has a fifty day moving average price of $2.00 and a 200-day moving average price of $3.84. Biodexa Pharmaceuticals has a 52 week low of $1.14 and a 52 week high of $74.00.

Biodexa Pharmaceuticals Company Profile

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.